Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
1.57M
-
Shares change
-
+799K
-
Total reported value, excl. options
-
$1.69M
-
Value change
-
+$856K
-
Number of buys
-
5
-
Number of sells
-
-3
-
Price
-
$1.08
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2017
11 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q2 2017.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.57M shares
of 112M outstanding shares and own 1.4% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (486K shares), VANGUARD GROUP INC (331K shares), RENAISSANCE TECHNOLOGIES LLC (299K shares), Park West Asset Management LLC (200K shares), Virtu KCG Holdings LLC (115K shares), GRT CAPITAL PARTNERS L.L.C. (85.6K shares), GEODE CAPITAL MANAGEMENT, LLC (31.3K shares), NORTHERN TRUST CORP (17K shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.99K shares), and UBS Group AG (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.